Microfracture Still Wants a Seat at the Biologics Table

Subscribe today to listen to this content Get Access

For years, microfracture has occupied an awkward place in knee preservation.

It is too old-school to feel cutting-edge, too familiar to be exciting and too often dismissed as yesterday’s answer to cartilage trouble. Meanwhile, stromal vascular fraction — SVF, the adipose-derived cell cocktail that keeps showing up in orthobiologic conversations — has carried the newer, shinier promise.